| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |




From the Department of Dermatopathology,*
Albany Medical
Center, Albany, New York; the Division of Pediatric
Oncology,
Dana Farber Cancer Institute and
Children's Hospital, Boston, Massachusetts; and the Department of
Dermatopathology,
Massachusetts General
Hospital, Boston, Massachusetts
Malignant melanomas do not uniformly retain expression of
melanocytic gene productsan observation associated with diagnostic
dilemmas. Microphthalmia transcription factor (Mitf) is a melanocytic
nuclear protein critical for the embryonic development and postnatal
viability of melanocytes. It serves as a master regulator in modulating
extracellular signals, such as those triggered by
-MSH and
c-Kit ligand. Because of its central role in melanocyte survival
and to assess its potential use as a histopathological marker for
melanoma, Mitf expression was examined in histologically
confirmed human melanoma specimens. Western blot analysis of melanoma
cell lines revealed consistent expression of two Mitf protein isoforms
differing by MAP kinase-mediated phosphorylation. In a series of 76
consecutive human melanoma surgical specimens, 100% stained
positively for Mitf with a nuclear pattern of reactivity. In a
side-by-side comparison, Mitf staining was positive in
melanomas that failed to stain for either HMB-45 or S-100, the
most common currently used melanoma markers. Of 60 non-melanoma
tumors, none displayed nuclear Mitf staining and two displayed
cytoplasmic staining. Although Mitf does not distinguish benign from
malignant melanocytic lesions, for invasive neoplasms it
appears to be a highly sensitive and specific histopathological
melanocyte marker for melanoma.
This article has been cited by other articles:
![]() |
J. N. Dynek, S. M. Chan, J. Liu, J. Zha, W. J. Fairbrother, and D. Vucic Microphthalmia-Associated Transcription Factor Is a Critical Transcriptional Regulator of Melanoma Inhibitor of Apoptosis in Melanomas Cancer Res., May 1, 2008; 68(9): 3124 - 3132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Becker, M. C. Mihm, S. M. Hewitt, V. K. Sondak, J. W. Fountain, and M. Thurin Markers and Tissue Resources for Melanoma: Meeting Report. Cancer Res., November 15, 2006; 66(22): 10652 - 10657. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Vlahos, C. W. Lipari, B. Bankowski, T.-H. Lai, J. A. King, I.-M. Shih, K. Fragakis, and Y. Zhao Effect of Luteal-Phase Support on Endometrial L-Selectin Ligand Expression after Recombinant Follicle-Stimulating Hormone and Ganirelix Acetate for in Vitro Fertilization J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4043 - 4049. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Miller and M. C. Mihm Jr. Melanoma. N. Engl. J. Med., July 6, 2006; 355(1): 51 - 65. [Full Text] [PDF] |
||||
![]() |
G. G. McGill, R. Haq, E. K. Nishimura, and D. E. Fisher c-Met Expression Is Regulated by Mitf in the Melanocyte Lineage J. Biol. Chem., April 14, 2006; 281(15): 10365 - 10373. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Goding and F. L. Meyskens Jr. Microphthalmic-Associated Transcription Factor Integrates Melanocyte Biology and Melanoma Progression Clin. Cancer Res., February 15, 2006; 12(4): 1069 - 1073. [Full Text] [PDF] |
||||
![]() |
K. Koyanagi, S. J. O'Day, R. Gonzalez, K. Lewis, W. A. Robinson, T. T. Amatruda, C. Kuo, H.-J. Wang, R. Milford, D. L. Morton, et al. Microphthalmia Transcription Factor as a Molecular Marker for Circulating Tumor Cell Detection in Blood of Melanoma Patients Clin. Cancer Res., February 15, 2006; 12(4): 1137 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Sra, M. Babb-Tarbox, S. Aboutalebi, P. Rady, G. L. Shipley, D. D. Dao, and S. K. Tyring Molecular Diagnosis of Cutaneous Diseases Arch Dermatol, February 1, 2005; 141(2): 225 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sharov, M. Fessing, R. Atoyan, T. Y. Sharova, C. Haskell-Luevano, L. Weiner, K. Funa, J. L. Brissette, B. A. Gilchrest, and V. A. Botchkarev Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway PNAS, January 4, 2005; 102(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Miller, J. Du, S. Rowan, C. L. Hershey, H. R. Widlund, and D. E. Fisher Transcriptional Regulation of the Melanoma Prognostic Marker Melastatin (TRPM1) by MITF in Melanocytes and Melanoma Cancer Res., January 15, 2004; 64(2): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Doglioni, S. Piccinin, S. Demontis, M. G. Cangi, L. Pecciarini, C. Chiarelli, M. Armellin, T. Vukosavljevic, M. Boiocchi, and R. Maestro Alterations of {beta}-Catenin Pathway in Non-Melanoma Skin Tumors: Loss of {alpha}-ABC Nuclear Reactivity Correlates with the Presence of {beta}-Catenin Gene Mutation Am. J. Pathol., December 1, 2003; 163(6): 2277 - 2287. [Abstract] [Full Text] |
||||
![]() |
J. Du, A. J. Miller, H. R. Widlund, M. A. Horstmann, S. Ramaswamy, and D. E. Fisher MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma Am. J. Pathol., July 1, 2003; 163(1): 333 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Durda, I. S. Dunn, L. B. Rose, D. Butera, E. M. Benson, F. Pandolfi, and J. T. Kurnick Induction of "Antigen Silencing" in Melanomas by Oncostatin M: Down-Modulation of Melanocyte Antigen Expression Mol. Cancer Res., April 1, 2003; 1(6): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Widlund, M. A. Horstmann, E. R. Price, J. Cui, S. L. Lessnick, M. Wu, X. He, and D. E. Fisher {beta}-Catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor J. Cell Biol., September 16, 2002; 158(6): 1079 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Altschmied, J. Delfgaauw, B. Wilde, J. Duschl, L. Bouneau, J.-N. Volff, and M. Schartl Subfunctionalization of Duplicate mitf Genes Associated With Differential Degeneration of Alternative Exons in Fish Genetics, May 1, 2002; 161(1): 259 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Selzer, V. Wacheck, T. Lucas, E. Heere-Ress, M. Wu, K. N. Weilbaecher, W. Schlegel, P. Valent, F. Wrba, H. Pehamberger, et al. The Melanocyte-specific Isoform of the Microphthalmia Transcription Factor Affects the Phenotype of Human Melanoma Cancer Res., April 1, 2002; 62(7): 2098 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du and D. E. Fisher Identification of Aim-1 as the underwhite Mouse Mutant and Its Transcriptional Regulation by MITF J. Biol. Chem., January 4, 2002; 277(1): 402 - 406. [Abstract] [Full Text] |
||||
![]() |
E. P. v. Strandmann, S. Senkel, G. Ryffel, and U. R. Hengge Dimerization Co-Factor of Hepatocyte Nuclear Factor 1/Pterin-4{{alpha}}-Carbinolamine Dehydratase Is Necessary for Pigmentation in Xenopus and Overexpressed in Primary Human Melanoma Lesions Am. J. Pathol., June 1, 2001; 158(6): 2021 - 2029. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Motyckova, K. N. Weilbaecher, M. Horstmann, D. J. Rieman, D. Z. Fisher, and D. E. Fisher Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family PNAS, April 25, 2001; (2001) 91479298. [Abstract] [Full Text] |
||||
![]() |
J. A. Ramos-Vara, M. E. Beissenherz, M. A. Miller, G. C. Johnson, L. W. Pace, A. Fard, and S. J. Kottler Retrospective Study of 338 Canine Oral Melanomas with Clinical, Histologic, and Immunohistochemical Review of 129 Cases Vet. Pathol., November 1, 2000; 37(6): 597 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Salti, T. Manougian, M. Farolan, A. Shilkaitis, D. Majumdar, and T. K. Das Gupta Micropthalmia Transcription Factor: A New Prognostic Marker in Intermediate-thickness Cutaneous Malignant Melanoma Cancer Res., September 1, 2000; 60(18): 5012 - 5016. [Abstract] [Full Text] |
||||
![]() |
C. R. Goding Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage Genes & Dev., July 15, 2000; 14(14): 1712 - 1728. [Full Text] |
||||
![]() |
M. Wu, T. J. Hemesath, C. M. Takemoto, M. A. Horstmann, A. G. Wells, E. R. Price, D. Z. Fisher, and D. E. Fisher c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi Genes & Dev., February 1, 2000; 14(3): 301 - 312. [Abstract] [Full Text] |
||||
![]() |
G. Motyckova, K. N. Weilbaecher, M. Horstmann, D. J. Rieman, D. Z. Fisher, and D. E. Fisher Linking osteopetrosis and pycnodysostosis: Regulation of cathepsin K expression by the microphthalmia transcription factor family PNAS, May 8, 2001; 98(10): 5798 - 5803. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |